scholarly journals Analysis of Brazilian Manufacters in the COVID-19 Diagnostic Products by ANVISA

2020 ◽  
Vol 3 (4) ◽  
pp. 312-318
Author(s):  
Valdir Gomes Barbosa Júnior ◽  
Roberto José da Silva Badaró ◽  
Bruna Aparecida Souza Machado
Keyword(s):  
World Health Organization ◽  
Regulatory Agency ◽  
Careful Analysis ◽  
World Health ◽  
Screening Tests ◽  
The World ◽  
Health Organization ◽  
External Dependence

In March 2020, the World Health Organization (WHO) declared COVID-19 as a pandemic. Diagnostic and screening tests have been important tools for the clinical characterization of diseases such as COVID-19. This study aimed to analyze the presence of Brazilian manufacturers in the COVID-19 products approved by the Brazilian Health Regulatory Agency (ANVISA). This research used the ANVISA database, in which 329 registered products were identified. We classified them into 4 methods, 3 of which were the object of careful analysis. The results showed Brazil’s external dependence on products from other countries, mainly from China.    

Epidemology: The role of the World Health Organization in the study of influenza

1980 ◽  
Vol 288 (1029) ◽  
pp. 417-421 ◽  
Keyword(s):  
World Health Organization ◽  
Diagnostic Procedures ◽  
Early Years ◽  
World Health ◽  
Isolation And Characterization ◽  
The World ◽  
Pandemic Strains ◽  
Health Organization

The World Health Organization (W.H.O.), since its inception in 1947, has given close attention to influenza. In its early years W.H.O. laid the foundations of its present network of over 100 national influenza centres and collaborating laboratories which today constitute the backbone of its influenza activities. The activities of the network include the isolation and characterization of influenza strains and the early notification of any changes in surface antigens, the preparation of reference reagents, standardization of diagnostic procedures, formulation of requirements for vaccines, training, and collaboration in research. The efficacy of the network has been proved in the 1957, 1968 and 1977 epidemics. Collaborative research organized by W.H.O. has made important contributions to our understanding of the epidemiology of influenza, including the possible role of lower animals as the origin of some pandemic strains. The latter subject is briefly discussed.

scholarly journals Contemporary Renal Tumor Categorization With Biomarker and Translational Updates: A Practical Review

2019 ◽  
Vol 143 (12) ◽  
pp. 1477-1491 ◽  
Author(s):  
Alexander S. Taylor ◽  
Daniel E. Spratt ◽  
Saravana M. Dhanasekaran ◽  
Rohit Mehra
Keyword(s):  
World Health Organization ◽  
Molecular Characterization ◽  
Renal Tumor ◽  
Tumor Classification ◽  
World Health ◽  
Renal Tumors ◽  
World Health Organization Classification ◽  
The World ◽  
Health Organization

Context.— Renal tumor classification has evolved in recent decades, as evidenced by the comparable complexity of the 2016 revision to the World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs. A recent expansion of the knowledge base surrounding the cells of origin and evolutionary genomic characteristics of renal tumors has led to molecular characterization of novel entities and enriched understanding of established entities. This pace of research and its implementation into clinical practice has again begun to surpass that of our own classification schemata, with significant discoveries having been made since the introduction of the 2016 revision to the World Health Organization classification. In particular, biomarkers for renal tumor diagnosis and prognosis are in translation for future clinical application. Objectives.— To provide a brief framework for clinical characterization of renal tumors rooted in morphologic assessment, to briefly review the current and future status of renal tumor biomarkers with an emphasis on practical use of these ancillary tools for accurate diagnosis, and to discuss the impact of emerging technologies and clinical trials relevant to renal cell carcinoma classification and biomarker development. Data Sources.— We review recent literature relevant to renal tumor classification (including established and proposed entities), focusing on molecular characterization and biomarker assessment. Conclusions.— Accurate renal tumor diagnosis requires an up-to-date understanding of renal tumor classification, including an awareness of morphologic clues that should stimulate consideration of molecularly defined entities, as well as the ancillary biomarker testing required to confirm diagnoses.

Erstes Instrument zur standardisierten Erfassung der Teilhabe Behinderter

2017 ◽  
Vol 79 (07) ◽  
pp. 526-527
Keyword(s):  
World Health Organization ◽  
World Health ◽  
The World ◽  
Health Organization ◽  
Menschen Mit Behinderung

Coenen M et al. [Recommendation for the collection and analysis of data on participation and disability from the perspective of the World Health Organization]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59: 1060–1067 Um eine gleichberechtigte Teilhabe an der Gesellschaft von Menschen mit Behinderung zu ermöglichen, werden zunächst Daten zu vorhandenen Einschränkungen gebraucht. Erst wenn diese detailliert erhoben wurden, können Konzepte zur Beseitigung von Problemen entwickelt werden. Ein standardisiertes Erhebungsinstrument für alle Aspekte der Funktionsfähigkeit fehlte jedoch bisher.

Recomendações de equipamentos de proteção individual no combate ao COVID-19

2020 ◽  
Vol 10 (31) ◽  
pp. 87-95
Author(s):  
Nicole Maria Miyamoto Bettini ◽  
Fabiana Tomé Ramos ◽  
Priscila Masquetto Vieira de Almeida
Keyword(s):  
World Health Organization ◽  
Personal Protective Equipment ◽  
Health Professionals ◽  
Health Personnel ◽  
Healthcare Professionals ◽  
World Health ◽  
Protective Equipment ◽  
Effective Strategy ◽  
The World ◽  
Health Organization

A Organização Mundial da Saúde - OMS confirmou a circulação internacional do novo Coronavírus em janeiro de 2020, nomeando-o como COVID-19 e, declarando uma pandemia. É de extrema importância que durante a pandemia, os profissionais de saúde tenham acesso e conhecimento sobre o uso correto dos Equipamentos de Proteção Individual (EPIs) e suas indicações, tomando assim, as devidas precauções na prevenção de infecções. O presente estudo buscou identificar a padronização mundial quanto ao uso dos EPIs utilizados no atendimento a pacientes suspeitos e/ou confirmados de COVID-19 no Brasil, EUA, China, Espanha, Itália e demais países europeus. Os guidelines apresentam a padronização quanto ao uso dos EPIs utilizados no atendimento a suspeitos e/ou confirmados de COVID-19, indo ao encontro das recomendações fornecidas pela OMS. Até o momento, o uso de EPIs é sem dúvida a estratégia mais importante e eficaz para proteger os profissionais de saúde durante a assistência ao paciente com COVID-19.Descritores: Infecções por Coronavírus, Equipamento de Proteção Individual, Pessoal de Saúde, Enfermagem. Recommendations for personal protective equipment to combat COVID-19Abstract: The World Health Organization - WHO confirmed the international circulation of the new Coronavirus in January 2020, naming it as COVID-19 and declaring a pandemic. It is extremely important that during the pandemic, health professionals have access and knowledge about the correct use of Personal Protective Equipment (PPE) and its indications, thus taking appropriate precautions to prevent infections. The present study sought to identify the worldwide standardization regarding the use of PPE utilized to take care of suspected and confirmed patients with COVID-19 in Brazil, USA, China, Spain, Italy and other European countries. The guidelines present a standardization regarding the use of PPE utilized to take care of suspected and confirmed with COVID-19, in line with the recommendations provided by WHO. To date, the use of PPE is undoubtedly the most important and effective strategy to protect healthcare professionals during care for patients with COVID-19.Descriptors: Coronavirus Infections, Personal Protective Equipment, Health Personnel, Nursing. Recomendaciones para el equipo de protección personal para combatir COVID-19Resumen: La Organización Mundial de la Salud - La OMS confirmó la circulación internacional del nuevo Coronavirus en enero de 2020, nombrándolo COVID-19 y declarando una pandemia. Es extremadamente importante que durante la pandemia, los profesionales de la salud tengan acceso y conocimiento sobre el uso correcto del Equipo de Protección Personal (EPP) y sus indicaciones, tomando así las precauciones adecuadas para prevenir infecciones. El presente estudio buscó identificar la estandarización mundial con respecto al uso de EPP utilizado para atender a pacientes sospechosos y/o confirmados con COVID-19 en Brasil, Estados Unidos, China, España, Italia y otros países europeos. Las pautas presentan la estandarización con respecto al uso de EPP utilizado para cuidar COVID-19 sospechoso y/o confirmado, de acuerdo con las recomendaciones proporcionadas por la OMS. Hasta la fecha, el uso de EPP es, sin duda, la estrategia más importante y efectiva para proteger a los profesionales de la salud durante la atención de pacientes con COVID-19.Descriptores: Infecciones por Coronavirus, Equipo de Protección Personal, Personal de Salud, Enfermería.

Sign in / Sign up

Export Citation Format

Share Document